4.6 Review

Health-related quality of life using the FACT-M questionnaire in patients with malignant melanoma: A systematic review

Journal

EJSO
Volume 48, Issue 2, Pages 312-319

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejso.2021.09.013

Keywords

FACT-M; Health-related quality of life; HRQOL; Malignant melanoma; PRISMA; Systematic review

Funding

  1. Knut and Alice Wallenberg Foundation
  2. Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden

Ask authors/readers for more resources

This study summarizes the HRQOL results using the FACT-M questionnaire in patients with melanoma and demonstrates an inverse correlation between FACT-M total scores and AJCC stage. The study highlights the importance for clinical studies to clearly describe their selected HRQOL questionnaires and comply with the guidelines when reporting data.
Background: Since there are no formal definition of health-related quality of life (HRQOL) there may be a lack of coherence and understanding of how to interpret HRQOL-data. The aim of this study is to summarize HRQOL-results that have used the FACT-M questionnaire in patients with melanoma, and specifically to summarize FACT-M between tumor stage. Methods: This review was conducted in accordance with the PRISMA guidelines. Inclusion criteria: original studies on cutaneous melanoma between 2005 and 2020, written in English, containing Functional Assessment of Cancer Therapy Melanoma OR Functional Assessment of Cancer Therapy M OR FACT-M OR FACT/M OR FACTM OR FACT M OR FACT-melanoma OR FACT Melanoma together with FACT-M numbered data and basic patient characteristics, using the databases Scopus, Web of Science, PubMed and PsycINFO. Results: 16 articles describing 14 patient cohorts published 2008-2020 were included. The majority of the studies did not report subscale scores in accordance with FACT-M guidelines. The results did indicate that FACT-M total scores were inversely correlated with AJCC stage. Subscale analysis demonstrated varying degrees of correlation with AJCC stage. The Melanoma Surgery Subscale score was lowest in stage III patients, probably reflecting more advanced surgical procedures in this group of patients. Conclusions: Though this review is based on a questionnaire limited to the assessment of melanoma patients, it highlights the universal need for clinical studies to describe their selected HRQOLquestionnaires, its definition of HRQOL and its dimensions, as well as comply with the questionnaire's guidelines when reporting HRQOL-data. (C) 2021 The Authors. Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available